Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones
National Cancer Institute (NCI)
National Cancer Institute (NCI)
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Medical University of South Carolina
M.D. Anderson Cancer Center
Novartis
Charles LeMoyne Hospital
South Valley University
Eli Lilly and Company
Wake Forest University Health Sciences
University Hospital, Lille
Weill Medical College of Cornell University
Ohio State University Comprehensive Cancer Center
Region Skane
Xijing Hospital
European University Miguel de Cervantes
Chinese University of Hong Kong
Region Jönköping County
Breast Cancer Trials, Australia and New Zealand
FindCure Biosciences (ZhongShan) Co., Ltd.
Shanghai Henlius Biotech
MediLink Therapeutics (Suzhou) Co., Ltd.
Hospital Universitario Lucus Augusti
Duke University
Baptist Health South Florida
Mario Negri Institute for Pharmacological Research
Baylor College of Medicine
Ondokuz Mayıs University
UNC Lineberger Comprehensive Cancer Center
Convalife (Shanghai) Co., Ltd.
Guizhou Provincial People's Hospital
Tianjin Medical University Cancer Institute and Hospital
University of Virginia
University Hospital, Grenoble
Montefiore Medical Center
Gustave Roussy, Cancer Campus, Grand Paris
Tanta University
Hospices Civils de Lyon
Kaiser Permanente
Fudan University
Institut du Cancer de Montpellier - Val d'Aurelle
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
AURA Health Technologies
Centre Antoine Lacassagne
Institut Bergonié
Umeå University
Virginia Commonwealth University
University Hospital, Lille
Cancer Care Hospital & Research Centre Foundation, Lahore
Fudan University
Aga Khan University